TY - JOUR
T1 - A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism
T2 - Lessons from Class B Crystal Structures
AU - Wootten, Denise
AU - Reynolds, Christopher A
AU - Koole, Cassandra
AU - Smith, Kevin J
AU - Mobarec, Juan C
AU - Simms, John
AU - Quon, Tezz
AU - Coudrat, Thomas
AU - Furness, Sebastian G B
AU - Miller, Laurence J
AU - Christopoulos, Arthur
AU - Sexton, Patrick M
N1 - Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2016/3
Y1 - 2016/3
N2 - The glucagon-like peptide 1 (GLP-1) receptor is a class B G protein-coupled receptor (GPCR) that is a key target for treatments for type II diabetes and obesity. This receptor, like other class B GPCRs, displays biased agonism, though the physiologic significance of this is yet to be elucidated. Previous work has implicated R2.60(190), N3.43(240), Q7.49(394), and H6.52(363) as key residues involved in peptide-mediated biased agonism, with R2.60(190), N3.43(240), and Q7.49(394) predicted to form a polar interaction network. In this study, we used novel insight gained from recent crystal structures of the transmembrane domains of the glucagon and corticotropin releasing factor 1 (CRF1) receptors to develop improved models of the GLP-1 receptor that predict additional key molecular interactions with these amino acids. We have introduced E6.53(364)A, N3.43(240)Q, Q7.49(394)N, and N3.43(240)Q/Q7.49(394)N mutations to probe the role of predicted H-bonding and charge-charge interactions in driving cAMP, calcium, or extracellular signal-regulated kinase (ERK) signaling. A polar interaction between E6.53(364) and R2.60(190) was predicted to be important for GLP-1- and exendin-4-, but not oxyntomodulin-mediated cAMP formation and also ERK1/2 phosphorylation. In contrast, Q7.49(394), but not R2.60(190)/E6.53(364) was critical for calcium mobilization for all three peptides. Mutation of N3.43(240) and Q7.49(394) had differential effects on individual peptides, providing evidence for molecular differences in activation transition. Collectively, this work expands our understanding of peptide-mediated signaling from the GLP-1 receptor and the key role that the central polar network plays in these events.
AB - The glucagon-like peptide 1 (GLP-1) receptor is a class B G protein-coupled receptor (GPCR) that is a key target for treatments for type II diabetes and obesity. This receptor, like other class B GPCRs, displays biased agonism, though the physiologic significance of this is yet to be elucidated. Previous work has implicated R2.60(190), N3.43(240), Q7.49(394), and H6.52(363) as key residues involved in peptide-mediated biased agonism, with R2.60(190), N3.43(240), and Q7.49(394) predicted to form a polar interaction network. In this study, we used novel insight gained from recent crystal structures of the transmembrane domains of the glucagon and corticotropin releasing factor 1 (CRF1) receptors to develop improved models of the GLP-1 receptor that predict additional key molecular interactions with these amino acids. We have introduced E6.53(364)A, N3.43(240)Q, Q7.49(394)N, and N3.43(240)Q/Q7.49(394)N mutations to probe the role of predicted H-bonding and charge-charge interactions in driving cAMP, calcium, or extracellular signal-regulated kinase (ERK) signaling. A polar interaction between E6.53(364) and R2.60(190) was predicted to be important for GLP-1- and exendin-4-, but not oxyntomodulin-mediated cAMP formation and also ERK1/2 phosphorylation. In contrast, Q7.49(394), but not R2.60(190)/E6.53(364) was critical for calcium mobilization for all three peptides. Mutation of N3.43(240) and Q7.49(394) had differential effects on individual peptides, providing evidence for molecular differences in activation transition. Collectively, this work expands our understanding of peptide-mediated signaling from the GLP-1 receptor and the key role that the central polar network plays in these events.
KW - Animals
KW - CHO Cells
KW - Cricetinae
KW - Cricetulus
KW - Crystallization
KW - Glucagon-Like Peptide 1
KW - Humans
KW - Hydrogen Bonding
KW - Models, Molecular
KW - Peptide Fragments
KW - Protein Binding
KW - Protein Structure, Secondary
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84962267960&partnerID=MN8TOARS
U2 - 10.1124/mol.115.101246
DO - 10.1124/mol.115.101246
M3 - Article
C2 - 26700562
SN - 0026-895X
VL - 89
SP - 335
EP - 347
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 3
ER -